StoneX Group’s Connect Biopharma Holdings CNTB Stock Holding History

StoneX Group’s Portfolio CNTB Stock Details CNTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$12.6K	Buy	+11,479	New	+$23.4K	﹤0.01%	1821

Other funds holding CNTB

Koa Wealth Management Encinitas, California $154M AUM 13.16% 1-Year Est. Return

Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

SmartHarvest Portfolios Poulsbo, Washington $258M AUM 39.79% 1-Year Est. Return

FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

StoneX Group's CNTB Position: Q3 2026 in Review

StoneX Group opened a new position in Connect Biopharma Holdings (CNTB) in Q3 2026: 11,479 shares worth $12.6K. The stake represents ﹤0.01% of the portfolio and ranks #1821 among its holdings.

11 funds tracked by Wall St. Rank hold CNTB as of Q3 2026.

StoneX Group held 11,479 shares of Connect Biopharma Holdings worth $12.6K as of Q3 2026.
Connect Biopharma Holdings was a new StoneX Group position in Q3 2026.
Connect Biopharma Holdings made up ﹤0.01% of StoneX Group's portfolio in Q3 2026, its #1821 holding.
11 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q3 2026.

Based on StoneX Group's 13F filing for Q3 2026, filed 3 Nov 2026.